MDCO – To Bleed Or Not To Bleed, They Answer The Question

The Medicines Company (MDCO – $30.92) – To Bleed Or Not Bleed, They Answer The Question New Recommendation – MDCO – The Medicines Company (MDCO) is a new recommendation at MTSL with a BUY UNDER 35 with TARGET PRICE of 50.  Focused on acute care medicine in the hospital setting, MDCO markets three proprietary drugs, has[…]

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.